Document Classification

Section Type: RESULTS

Text: FEC14 therapy, compared with FEC21 therapy, was associated with more asthenia (36 % versus 29 %, difference = 7 %, 95 % CI = 2 % to 12 % ; P =. 01), bone pain (33 % versus 4 %, difference = 29 %, 95 % CI = 25 % to 33 % ; P <. 001), anemia (38 % versus 19 %, difference = 19 %, 95 % CI = 14 % to 24 % ; P <. 001), and thrombocytopenia (8 % versus 2 %, difference = 6 %, 95 % CI = 4 % to 9 % ; P <. 001), but with less leukopenia (12 % versus 45 %, difference = 33 %, 95 % CI = 28 % to 37 % ; P <. 001).